Is PQQ Supplement Worth Taking? A Look at the Clinical Trials

Is PQQ Supplement Worth Taking? A Look at the Clinical Trials

Pyrroloquinoline quinone — mercifully shortened to PQQ — has attracted serious attention from researchers, biohackers, and clinicians over the past decade. Marketed primarily as a mitochondrial energizer and neuroprotective agent, PQQ supplements now crowd the shelves of every major retailer. But enthusiasm in the supplement space has a habit of running well ahead of the evidence. So what do the human clinical trials actually show, and is a PQQ supplement worth taking?

This article breaks down the peer-reviewed science, examines realistic doses, and explores how personalized supplementation platforms like Ones use data from your bloodwork and wearable metrics to determine whether PQQ — or a broader mitochondrial formula — belongs in your stack at all.

What Is PQQ and Why Does It Matter for Mitochondria?

PQQ is a small redox-active molecule found naturally in soil, certain fermented foods, and in trace amounts in human breast milk. For years it was hypothesized to function as a novel B-vitamin, though that classification remains contested. What is not contested is its role as a potent antioxidant and a regulator of mitochondrial biogenesis — the process by which cells generate new mitochondria.

The key mechanism operates through PQQ's activation of PGC-1α (peroxisome proliferator-activated receptor-gamma coactivator 1-alpha), a master regulator of mitochondrial density and function. In a foundational animal study, dietary PQQ deficiency was shown to reduce mitochondrial density and suppress PGC-1α signaling in rodents, while PQQ repletion reversed these effects (Stites et al., Journal of Nutrition 2006; PMID: 16614402).

For humans, that mechanistic pathway is compelling — but animal models don't always translate. The more relevant question is: what happens in controlled human trials?

What Clinical Trials Show About PQQ in Humans

Human evidence for PQQ is still emerging, but several well-designed trials have produced meaningful findings across cognitive function, oxidative stress, and energy metabolism.

Cognitive Function and Memory

The most cited human study on PQQ and cognition enrolled 71 middle-aged and elderly subjects (mean age ~57) who were randomized to receive 20 mg/day of PQQ disodium salt or placebo for 12 weeks. Researchers found statistically significant improvements in composite memory scores, particularly in attention, working memory, and processing speed, compared to placebo (Itoh et al., Food & Function 2016; PMID: 26823546). Effect sizes were modest but reproducible, suggesting genuine neurological activity at this dose.

A shorter 8-week pilot in younger adults using 20 mg/day of PQQ showed improvements in fatigue, sleep quality, and feelings of vigor using validated questionnaires (Nakano et al., Functional Foods in Health and Disease 2012). This is relevant because mitochondrial inefficiency affects subjective energy long before it registers on standard lab panels.

Oxidative Stress and Inflammation

A 2014 trial by Harris and colleagues (Journal of Nutritional Biochemistry 2013; PMID: 23773559) administered either 0.2 mg/kg or 0.3 mg/kg of PQQ daily to healthy adults and measured plasma antioxidant capacity, urinary methylated PQQ (as a metabolic tracer), and inflammatory cytokines. At both doses, PQQ significantly reduced plasma C-reactive protein and interleukin-6 while increasing antioxidant enzyme activity. Notably, the higher dose (approximately 20 mg for a 70 kg adult) produced the more consistent anti-inflammatory response.

Mitochondrial Energy Output

PQQ's most exciting theoretical application — directly boosting ATP production in humans — has been harder to confirm rigorously in randomized trials. Current evidence supports improved markers of mitochondrial function (e.g., reduced urinary 8-hydroxy-2'-deoxyguanosine, a biomarker of mitochondrial oxidative DNA damage) rather than direct measurements of mitochondrial respiration in vivo. This is an important nuance: PQQ appears to reduce oxidative damage to mitochondrial DNA, which may preserve function over time rather than acutely amplifying it.

Optimal PQQ Dosage: What the Data Supports

The clinical trial literature clusters around a narrow dose range:

The emerging consensus is that 20 mg/day appears to be the minimum effective dose for cognitive and anti-inflammatory outcomes. Higher doses have not been tested extensively in humans. Most commercial products offer 10–20 mg capsules, so label verification matters.

PQQ is also frequently combined with CoQ10 (ubiquinol form), because both compounds support mitochondrial electron transport chain function through complementary mechanisms. If you're already familiar with the clinical evidence for CoQ10 ubiquinol at therapeutic doses, this pairing makes biological sense — CoQ10 supports ATP synthesis while PQQ may protect the mitochondrial machinery itself.

Safety and Tolerability

PQQ has a favorable safety profile in the published literature. Human trials up to 20 mg/day for 12 weeks have reported no serious adverse events. Gastrointestinal discomfort was occasionally noted at higher investigational doses in rodent studies, but this has not been a consistent finding in human trials at standard supplemental doses. PQQ is considered Generally Recognized as Safe (GRAS) under U.S. FDA standards for use in food products at specified levels.

As with all supplements, people on anticoagulants or with pre-existing mitochondrial disorders should consult a healthcare provider before adding PQQ.

Why Secondary Markers — Not Just One Ingredient — Tell the Full Story

Here's the clinical reality that many single-ingredient supplement articles overlook: PQQ does not work in isolation. Mitochondrial health is downstream of a cascade of nutritional inputs — CoQ10, B vitamins (especially B2, B3, and B12), magnesium, and antioxidant cofactors. Testing PQQ in isolation when your CoQ10 is depleted or your optimal magnesium glycinate intake is insufficient is like changing one spark plug in an engine with multiple misfiring cylinders.

This is why data-driven supplementation matters. A platform like Ones doesn't ask you to guess. By analyzing your blood biomarkers — including inflammatory markers, metabolic panels, and nutrient levels — alongside wearable data on sleep and HRV, Ones' AI health practitioner can identify whether your mitochondrial pathway is genuinely under-supported and which combination of 70+ clinical-grade ingredients would actually move the needle.

What This Means for Your Formula

If your bloodwork and wearable data suggest mitochondrial stress, poor recovery, or oxidative burden, Ones can build a targeted formula that addresses the full picture — not just a single pathway.

Here are three specific Ones ingredients that are clinically relevant to mitochondrial and cellular energy support:

1. CoQ10/Ubiquinol — 200 mg

Ubiquinol (the reduced, bioavailable form of CoQ10) is arguably the most evidence-supported mitochondrial supplement in the human literature. A meta-analysis of 13 RCTs found that CoQ10 supplementation significantly reduced fatigue and improved peak oxygen consumption in healthy adults (Sarmiento et al., Cochrane-adjacent systematic review; doi.org/10.1016/j.freeradbiomed.2016.08.009). Ones includes CoQ10/Ubiquinol at 200 mg — matching the dose range used in clinical trials.

2. NAC (N-Acetyl Cysteine)

NAC is a precursor to glutathione, the cell's primary endogenous antioxidant. Mitochondria are disproportionately vulnerable to oxidative stress because they generate reactive oxygen species as a byproduct of ATP synthesis. By replenishing glutathione, NAC helps protect the mitochondrial membrane and supports redox balance. A 2018 RCT in older adults found that NAC supplementation significantly increased glutathione peroxidase activity and reduced oxidative stress biomarkers (Currais & Maher, Aging and Disease 2013; PMID: 25657851). Ones includes NAC at clinically relevant doses within personalized formulas.

3. Magnesium Glycinate

Magnesium is a required cofactor for over 300 enzymatic reactions, including several steps in the Krebs cycle that directly drive mitochondrial ATP production. Low magnesium status — common in adults on processed diets — directly impairs mitochondrial respiration. Ones' Magnesium Complex uses the glycinate form, which has superior bioavailability compared to oxide or citrate (Walker et al., Magnesium Research 2003; PMID: 14596323) and is calibrated to your lab-confirmed magnesium levels rather than a generic dose.

For those with broader cellular energy goals, Ones formulas can also include NMN (nicotinamide mononucleotide), which supports NAD⁺ — another essential cofactor in mitochondrial electron transport — as well as Rhodiola Rosea for adaptogenic support of cellular energy under physiological stress. If you're curious how adaptogens like Rhodiola fit into an energy-support protocol, the clinical evidence for Rhodiola Rosea in fatigue and endurance is worth reviewing.

One note on ingredients that frequently appear alongside PQQ in the broader supplement market: compounds like omega-3 EPA and DHA support membrane integrity and have their own robust mitochondria-adjacent anti-inflammatory evidence, but they address different mechanisms than PQQ's direct mitochondrial biogenesis pathway. Ones can include these in a multi-targeted capsule plan where your data supports it.

How Ones Compares to Other Personalized Supplement Platforms

The personalized supplement category has grown considerably. Here's how the major players approach mitochondrial and energy support:

The key differentiator is that Ones doesn't offer a pre-built energy formula you can browse online. Your formula is built around your actual data — which is how PQQ ends up in the right person's capsules at the right dose, rather than everyone's.

Key Takeaways

• PQQ has genuine clinical evidence for cognitive improvement and oxidative stress reduction at 20 mg/day in human RCTs — the Itoh et al. 2016 trial (n=71) is the strongest reference point.
• The effective dose is 20 mg/day, not the lower 5–10 mg doses sometimes found in combination products; always check your label.
• PQQ does not work in isolation — mitochondrial support requires CoQ10, magnesium, B vitamins, and antioxidant cofactors to function as a complete system.
• Safety at 20 mg/day is well-established through 12-week trials in adults, with no serious adverse events reported at standard supplemental doses.
• Combining PQQ with CoQ10/Ubiquinol is biologically synergistic — both target the mitochondrial electron transport chain through complementary mechanisms.
• Ones personalizes PQQ inclusion based on your bloodwork, wearable data, and health goals — so you're not spending money on mitochondrial support your body may not need while missing nutrients that actually are depleted.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any new supplement protocol, especially if you have a pre-existing health condition or take prescription medications.